213 related articles for article (PubMed ID: 30008670)
1. Patient-Specific iPSC-Based Models of Huntington's Disease as a Tool to Study Store-Operated Calcium Entry Drug Targeting.
Vigont V; Nekrasov E; Shalygin A; Gusev K; Klushnikov S; Illarioshkin S; Lagarkova M; Kiselev SL; Kaznacheyeva E
Front Pharmacol; 2018; 9():696. PubMed ID: 30008670
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Neuronal Calcium Signaling via Store-Operated Channels in Huntington's Disease.
Czeredys M
Front Cell Dev Biol; 2020; 8():611735. PubMed ID: 33425919
[TBL] [Abstract][Full Text] [Related]
3. STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease.
Vigont VA; Grekhnev DA; Lebedeva OS; Gusev KO; Volovikov EA; Skopin AY; Bogomazova AN; Shuvalova LD; Zubkova OA; Khomyakova EA; Glushankova LN; Klyushnikov SA; Illarioshkin SN; Lagarkova MA; Kaznacheyeva EV
Front Cell Dev Biol; 2021; 9():625231. PubMed ID: 33604336
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
5. Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.
Latoszek E; Czeredys M
Front Cell Dev Biol; 2021; 9():657337. PubMed ID: 33869222
[TBL] [Abstract][Full Text] [Related]
6. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
7. Both Orai1 and TRPC1 are Involved in Excessive Store-Operated Calcium Entry in Striatal Neurons Expressing Mutant Huntingtin Exon 1.
Vigont V; Kolobkova Y; Skopin A; Zimina O; Zenin V; Glushankova L; Kaznacheyeva E
Front Physiol; 2015; 6():337. PubMed ID: 26635623
[TBL] [Abstract][Full Text] [Related]
8. Huntingtin-Associated Protein 1A Regulates Store-Operated Calcium Entry in Medium Spiny Neurons From Transgenic YAC128 Mice, a Model of Huntington's Disease.
Czeredys M; Vigont VA; Boeva VA; Mikoshiba K; Kaznacheyeva EV; Kuznicki J
Front Cell Neurosci; 2018; 12():381. PubMed ID: 30455632
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the calcium signaling alterations in GABA-ergic medium spiny neurons produced from iPSCs of different origins.
Oshkolova AA; Grekhnev DA; Kruchinina AA; Belikova LD; Volovikov EA; Lebedeva OS; Bogomazova AN; Vigont VA; Lagarkova MA; Kaznacheyeva EV
Biochimie; 2024 Jul; 222():63-71. PubMed ID: 38163516
[TBL] [Abstract][Full Text] [Related]
10. The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies.
Grekhnev DA; Kruchinina AA; Vigont VA; Kaznacheyeva EV
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555369
[TBL] [Abstract][Full Text] [Related]
11. Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington's disease.
Czeredys M; Maciag F; Methner A; Kuznicki J
Biochem Biophys Res Commun; 2017 Feb; 483(4):1194-1205. PubMed ID: 27553284
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.
Wu J; Ryskamp D; Birnbaumer L; Bezprozvanny I
J Huntingtons Dis; 2018; 7(1):35-50. PubMed ID: 29480205
[TBL] [Abstract][Full Text] [Related]
13. The store-operated calcium entry pathways in human carcinoma A431 cells: functional properties and activation mechanisms.
Gusev K; Glouchankova L; Zubov A; Kaznacheyeva E; Wang Z; Bezprozvanny I; Mozhayeva GN
J Gen Physiol; 2003 Jul; 122(1):81-94. PubMed ID: 12835472
[TBL] [Abstract][Full Text] [Related]
14. The difficulty to model Huntington's disease in vitro using striatal medium spiny neurons differentiated from human induced pluripotent stem cells.
Le Cann K; Foerster A; Rösseler C; Erickson A; Hautvast P; Giesselmann S; Pensold D; Kurth I; Rothermel M; Mattis VB; Zimmer-Bensch G; von Hörsten S; Denecke B; Clarner T; Meents J; Lampert A
Sci Rep; 2021 Mar; 11(1):6934. PubMed ID: 33767215
[TBL] [Abstract][Full Text] [Related]
15. Calcium dysregulation and compensation in cortical pyramidal neurons of the R6/2 mouse model of Huntington's disease.
Oikonomou KD; Donzis EJ; Bui MTN; Cepeda C; Levine MS
J Neurophysiol; 2021 Oct; 126(4):1159-1171. PubMed ID: 34469694
[TBL] [Abstract][Full Text] [Related]
16. The Molecular Heterogeneity of Store-Operated Ca
Moccia F; Brunetti V; Perna A; Guerra G; Soda T; Berra-Romani R
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834672
[TBL] [Abstract][Full Text] [Related]
17. On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases.
Secondo A; Bagetta G; Amantea D
Front Mol Neurosci; 2018; 11():87. PubMed ID: 29623030
[TBL] [Abstract][Full Text] [Related]
18. Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.
Wu J; Shih HP; Vigont V; Hrdlicka L; Diggins L; Singh C; Mahoney M; Chesworth R; Shapiro G; Zimina O; Chen X; Wu Q; Glushankova L; Ahlijanian M; Koenig G; Mozhayeva GN; Kaznacheyeva E; Bezprozvanny I
Chem Biol; 2011 Jun; 18(6):777-93. PubMed ID: 21700213
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
